The company in question is, Smith & Nephew plc (NYSE:SNN) currently with a stock price of 33.41 (-0.21% today). The market cap for Smith & Nephew plc is 14965.56, and is in the sector Healthcare, and Medical Appliances & Equipment industry. The target price for Smith & Nephew plc is 40.67. Currently Smith & Nephew plc is trading with a P/E of 42.17, and a forward P/E of 17.29. Average volume for Smith & Nephew plc is 449.37 and so far today it is 158314.
Performance in the last year for Smith & Nephew plc has been -7.67%. For EPS growth, Smith & Nephew plc has seen a growth of -18.20%, and is looking to grow in the next year to 13.35%. More long term stats show that EPS growth has been -7.80% over the last five years and could be 7.10% for the next five years. Smith & Nephew plc has seen sales growth quarter over quarter at 2.50%, with EPS growth quarter over quarter at -18.30%. The 20-day simple moving average is -1.54%, with the 200-day simple moving average coming to 0.15%.
Since the IPO date for Smith & Nephew plc on the 11/16/1999, Smith & Nephew plc has seen performance year to date to be -4.92%. With Smith & Nephew plc trading at 33.41, the dividend yield is 2.27%, and the EPS is 0.79.
So could Smith & Nephew plc, be undervalued? Well as said before P/E is 42.17. The PEG is 5.94, P/S is 3.19 and the P/B is at 3.8. The P/cash is 176.07, with P/free cash flow at *TBA.
Smith & Nephew plc ability to deal with debt shows that the current ratio is 1.9, and the quick ratio is 0.9. This is with long term debt/equity at 0.43, and total debt/equity at 0.45.
In terms of margins, Smith & Nephew plc has a gross margin of 74.20%, an operating margin of *TBA and a profit margin of *TBA.Payout ratio for Smith & Nephew plc is *TBA. Return on assets come to *TBA with return on investment coming to 8.80%.
Insider ownership for Smith & Nephew plc, is at 0.60% and institutional ownership comes to 5.90%. Outstanding shares are at 447. While shares float is 444.73. The float short is currently 0.32%, and short ratio is 3.2.